-
λ1-rhodium(1+) ion (2S,5S)-1-{2-[(2S,5S)-2,5-dimethylphospholan-1-yl]ethyl}-2,5-dimethylphospholane cycloocta-1,5-diene tetrafluoroboranuide
-
ChemBase ID:
140537
-
Molecular Formular:
C22H40BF4P2Rh
-
Molecular Mass:
556.2106348
-
Monoisotopic Mass:
556.16894682
-
SMILES and InChIs
SMILES:
[B-](F)(F)(F)F.C[C@@H]1P([C@H](CC1)C)CCP1[C@H](CC[C@@H]1C)C.C1C=CCCC=CC1.[Rh+]
Canonical SMILES:
C1CC=CCCC=C1.F[B-](F)(F)F.C[C@H]1CC[C@@H](P1CCP1[C@@H](C)CC[C@@H]1C)C.[Rh+]
InChI:
InChI=1S/C14H28P2.C8H12.BF4.Rh/c1-11-5-6-12(2)15(11)9-10-16-13(3)7-8-14(16)4;1-2-4-6-8-7-5-3-1;2-1(3,4)5;/h11-14H,5-10H2,1-4H3;1-2,7-8H,3-6H2;;/q;;-1;+1/t11-,12-,13-,14-;;;/m0.../s1
InChIKey:
CVUPEPGZCZHSOF-FZUZUFHQSA-N
-
Cite this record
CBID:140537 http://www.chembase.cn/molecule-140537.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
λ1-rhodium(1+) ion (2S,5S)-1-{2-[(2S,5S)-2,5-dimethylphospholan-1-yl]ethyl}-2,5-dimethylphospholane cycloocta-1,5-diene tetrafluoroboranuide
|
|
|
IUPAC Traditional name
|
λ1-rhodium(1+) ion (2S,5S)-1-{2-[(2S,5S)-2,5-dimethylphospholan-1-yl]ethyl}-2,5-dimethylphospholane 1,5-cyclooctadiene tetrafluoroborate
|
|
|
Synonyms
|
1,2-Bis[(2S,5S)-2,5-dimethylphospholano]ethane(cyclooctadiene)rhodium(I) tetrafluoroborate
|
1,2-双[(2S,5S)-2,5-二甲基磷]乙烷(环辛二烯)四氟硼酸铑(I)
|
|
|
CAS Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Polarizability
|
30.505253 Å3
|
Polar Surface Area
|
0.0 Å2
|
Rotatable Bonds
|
3
|
Lipinski's Rule of Five
|
false
|
H Acceptors
|
0
|
H Donor
|
0
|
LogD (pH = 5.5)
|
1.2993337
|
LogD (pH = 7.4)
|
1.9907631
|
Log P
|
2.8812
|
Molar Refractivity
|
84.903 cm3
|
DETAILS
DETAILS
Sigma Aldrich
Sigma Aldrich -
675547
|
Packaging 100, 500 mg in glass bottle Legal Information Sold in collaboration with Kanata Chemical Technologies Inc. for research purposes only. These compounds were made and sold under license from E.I. du Pont de Nemours and Company, which license does not include the right to use the compounds in producing products for sale in the pharmaceutical field. Application DuPhos and BPE Ligands: Highly Efficient Privileged LigandsCatalyst for: • Asymmetric hydrogenation1,2 |
PATENTS
PATENTS
PubChem Patent
Google Patent